Abstract
The small heat shock protein αB-crystallin was recently identified as a dominant human T-cell antigen in myelin derived from multiple sclerosis (MS) patients. Using immunohistochemical techniques, oligodendrocytes as well as astrocytes in MS lesions were shown to express αB-crystallin. In the present study we examined the expression of αB-crystallin, human natural killer cell marker (HNK-1; as a marker for immature oligodendrocytes) and heat shock protein 60 (hsp60) in glia cells at different stages of MS lesion development i.e. in early active lesions, late active lesions and inactive lesions. The results demonstrate that already at the earliest stages of lesional development a subpopulation of oligodendrocytes express detectable levels of αB-crystallin. In active lesions about 5–10% of all oligodendrocytes were found to express αB-crystallin, whereas in inactive lesions the relative number of αB-crystallin-expressing oligodendrocytes was approximately tenfold less. For astrocytes the relative number of αB-crystallin-expressing cells was 40–50% for all three types of lesions. Also, αB-crystallin-expressing oligodendrocytes and astrocytes displayed different patterns of distribution in lesional areas. These data suggest different regulatory pathways for αB-crystallin expression in either type of glia cell. No correlation was found between expression patterns of HNK-1 and αB-crystallin indicating that the subpopulation of αB-crystallin-expressing oligodendrocytes consisted of both mature and immature oligodendrocytes. In addition, no correlation was found between expression of hsp60 and αB-crystallin in MS lesions suggesting different regulatory pathways for either hsp.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have